8-K
filed May 27, 2026, 8:10 AM ET
ticker TTRX
CIK 0002023016
other material
confidence high
sentiment positive
materiality 0.50
Turn Therapeutics announces peer-reviewed publication supporting GX-03's activity in IL-36 inflammatory model
Turn Therapeutics Inc.
- Study in murine dermatitis model showed mean IGA score of 1.44 vs 3.00 for untreated controls (p=0.0003) after 7 days of GX-03.
- No treatment-related adverse effects observed; IL-36 expression confirmed following Staphylococcus aureus exposure.
- Publication in Journal of Dermatological Treatment; first in planned series on GX-03's scientific rationale.
- GX-03 is in Phase 2 for moderate-to-severe atopic dermatitis; topline results expected mid-2026.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001213900-26-061244
- form_type
- 8-K
- ticker
- TTRX
- cik
- 0002023016
- company_name
- Turn Therapeutics Inc.
- filed_at
- 2026-05-27T12:10:30+00:00
- discovered_at
- 2026-05-27T12:15:00.500666+00:00
- generated_at
- 2026-05-27T12:15:55.358667+00:00
- sec_items
- ["7.01", "9.01"]
- event_type
- other_material
- sentiment
- positive
- materiality_score
- 0.5
- calibrated_materiality_score
- 0.5
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001213900-26-061244
- json_url
- https://secwatch.observer/filing/0001213900-26-061244.json
- markdown_url
- https://secwatch.observer/filing/0001213900-26-061244.md
- text_url
- https://secwatch.observer/filing/0001213900-26-061244.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/2023016/000121390026061244/0001213900-26-061244-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/2023016/000121390026061244/ea0291866-8k_turn.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
SMC
Summit Midstream Corporation announces inaugural $35 million stock repurchase program
Summit Midstream Corp
June 1, 2026, 4:31 PM ET
other_material
Items 7.01, 9.01
same SEC item: 7.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
LTRX
Lantronix prices $30M common stock offering at $7.20/share; net proceeds ~$32.3M
LANTRONIX INC
June 1, 2026, 4:15 PM ET
other_material
Items 1.01, 7.01, 9.01
same SEC item: 7.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
RMR
RMR highlights $37B AUM, 40%+ EBITDA margins, and $120M liquidity in investor presentation
RMR GROUP INC.
June 1, 2026, 4:11 PM ET
other_material
Items 7.01, 9.01
same SEC item: 7.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
EDAP
EDAP TMS holds FocalTherics Investor Day; plans to exit ESWL and distribution segments to focus on HIFU
EDAP TMS SA
June 1, 2026, 4:05 PM ET
other_material
Items 7.01, 9.01
same SEC item: 7.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
ATRO
Astronics announces 20% Class B stock distribution to all shareholders
ASTRONICS CORP
June 1, 2026, 9:05 AM ET
other_material
Items 7.01, 9.01
same SEC item: 7.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
CABR
Caring Brands expands licensing deal for Photocil and Hair Enzyme Booster to 5-year term, new territories
Caring Brands, Inc.
June 1, 2026, 8:05 AM ET
other_material
Items 7.01, 9.01
same SEC item: 7.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
INVH
InvH April-May SS occupancy 97.2%, rent growth 2.5%; valuation discount to NAV
Invitation Homes Inc.
June 1, 2026, 6:45 AM ET
other_material
Items 7.01, 9.01
same SEC item: 7.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
CRM
Salesforce shareholders approve 34M share equity plan increase, extend term to 2036, all directors re-elected
Salesforce, Inc.
June 1, 2026, 4:43 PM ET
other_material
Items 5.07, 5.02, 9.01
same SEC item: 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.